SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Geaslen Judith S.T.

(Last) (First) (Middle)
C/O CURAXIS PHARMACUETICAL CORP
4819 EMPEROR BLVD, SUITE 400

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/29/2010
3. Issuer Name and Ticker or Trading Symbol
CURAXIS PHARMACEUTICAL Corp [ ASCH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President - Finance
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 9,800(1) D
Common Stock 10,000 I By Spouse
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option 12/01/2009(2) 12/01/2014 Common Stock 3,500 $4 D
Employee Stock Option 01/17/2006(3) 01/17/2015 Common Stock 5,000 $8 D
Employee Stock Option 05/04/2006(4) 05/04/2016 Common Stock 1,000 $10 D
Employee Stock Option 01/01/2007(5) 05/18/2016 Common Stock 20,000 $6 D
Employee Stock Option 01/01/2007(5) 05/18/2016 Common Stock 5,000 $6 D
Employee Stock Option 01/01/2008(6) 05/17/2017 Common Stock 30,000 $1.51 D
Employee Stock Option 02/19/2009(7) 02/19/2019 default 100,000 $0.2 D
Employee Stock Option 01/18/2011(8) 01/18/2020 Common Stock 50,000 $0.2 D
Explanation of Responses:
1. Includes 5,800 share held jointly with spouse, Donald P. Geaslen.
2. Stock options vested at 20% of the shares on December 1, 2005 and 20% vested on each December 1st thereafter based on continued employment through December 1, 2009.
3. These stock options vested as to 20% of the shares on January 17, 2006 and 20% vested on each January 17th thereafter based on continued employment through January 17, 2010.
4. These stock options vested as to 20% of the shares on May 4, 2006 and 20%vested on each May 4th thereafter based on continued employment through May, 4 2010.
5. These Stock options vest as to 20% on January 1, 2007 and 20% on each January 1st thereafter based on continued employment through January 1, 2011.
6. These Stock options vest as to 20% on January 1, 2008 and 20% on each January 1st thereafter based on continued employment through January 1, 2012.
7. These stock options vested as to 100% on the grant date of February 19, 2009.
8. These Stock options vest as to 20% on January 18, 2011 and 20% on each January 18th thereafter based on continued employment through January 1, 2015.
/s/ Judith S. T. Geaslen 08/06/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.